Cancer Genetics Inc operates in the Medical laboratories sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Cancer Genetics Inc with three other
pharmaceutical manufacturers in North America:
Biocryst Pharmaceuticals Inc
sales of $26.35 million
of which 100%
Acceleron Pharma Inc
of which 63%
was Ingredients Segments).
Cancer Genetics Inc reported sales of $27.05 million
December of 2016.
increase of 49.9%
versus 2015, when the company's sales were $18.04 million.
Sales at Cancer Genetics Inc have increased during each of the previous five years
(and since 2011, sales have increased a total of 796%).